Gram-Negative Bacterial Infections  >>  Nimenrix (MenACWY-TT)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

13 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nimenrix (MenACWY-TT) / Pfizer
NCT00453986: Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Completed
3
1352
RoW
Meningococcal vaccine GSK134612, Mencevax™ACWY, Fluarix™
GlaxoSmithKline
Infections, Meningococcal
11/07
05/08
NCT00464815 / 2012-000282-20: Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Completed
3
1025
RoW
Meningococcal vaccine GSK134612, Mencevax™ ACWY
GlaxoSmithKline
Infections, Meningococcal
04/08
09/08
NCT00465816 / 2006-005999-41: Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

Completed
3
611
Europe
Nimenrix (Meningococcal vaccine 134612), Twinrix
GlaxoSmithKline
Infections, Meningococcal
04/08
04/08
NCT00508261 / 2006-006680-23: Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

Completed
3
793
Europe
Meningococcal vaccine GSK134612, Infanrix™ hexa, Meningitec™
GlaxoSmithKline
Infections, Meningococcal
05/08
10/08
NCT00758264: Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

Completed
3
363
RoW
Meningococcal vaccine GSK134612, Pneumococcal vaccine GSK1024850A
GlaxoSmithKline
Infections, Meningococcal
06/09
11/09
NCT00614614 / 2012-002401-22: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

Completed
3
1558
US
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix), Nimenrix, GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix), Menhibrix, Infanrix®, ActHIB®, Pediarix®
GlaxoSmithKline
Infections, Meningococcal
07/09
09/09
NCT01154088: Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds

Completed
3
1170
RoW
Mencevax ACWY, GSK Biologicals' meningococcal serogroup A, C, W-135, Y tetanus toxoid conjugate investigational vaccine [GSK 134612]
GlaxoSmithKline
Infections, Meningococcal
12/10
12/10
NCT01235975: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Completed
3
400
RoW
Meningococcal vaccine GSK 134612, MencevaxACWY TM
GlaxoSmithKline
Infections, Meningococcal
07/11
08/11
NCT00974363 / 2012-005641-21: Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Completed
3
697
RoW
Blood Sampling
GlaxoSmithKline
Infections, Meningococcal
05/13
05/13
NCT01767376 / 2012-002737-11: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Completed
3
692
Europe, RoW
Meningococcal vaccine GSK134612, MenACWY-TT, Nimenrix, Boostrix®, Tdap
GlaxoSmithKline
Infections, Meningococcal
01/14
01/14
NCT01755689 / 2012-001876-13: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

Completed
3
1300
Europe, RoW
Meningococcal vaccine GSK134612, Nimenrix®, Cervarix®, Boostrix®
GlaxoSmithKline
Infections, Meningococcal
04/14
04/14
NCT01777308 / 2012-002575-34: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Completed
3
156
RoW
Meningococcal conjugate vaccine GSK134612
GlaxoSmithKline
Infections, Meningococcal
07/14
04/16
NCT01641042 / 2011-002410-36: Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Completed
3
86
US, RoW
Meningococcal vaccine GSK134612
GlaxoSmithKline
Infections, Meningococcal
10/14
03/15

Download Options